21 May 2013
Keywords: santarus, licenses, cosmo, mmx, drugs, usa, usa-based
Article | 12 January 2009
USA-based Santarus has licensed Cosmo Pharmaceuticals SpA's two drugs Budesonide MMX and Rifamycin SV MMX for its domestic market. Under ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
20 May 2013
© 2013 thepharmaletter.com